Patent · US Active

RSV-specific antibodies and functional parts thereof

US11661449B2 · kind B2 · utility

1Cited by
15References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 22, 2021
Grant dateMay 30, 2023
Priority date
Expiry dateOct 22, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/90
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This application provides antibodies and functional equivalents thereof which are capable of specifically binding RSV, as well as means and methods for producing them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.